Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECUKINUMAB vs SEMAGLUTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SECUKINUMAB vs SEMAGLUTIDE: Safety Overview

Metric SECUKINUMAB SEMAGLUTIDE
Total FAERS Reports 151,223 59,604
Deaths Reported 6,855 792
Death Rate 4.5% 1.3%
Hospitalizations 19,098 11,258
Average Patient Age 52.3 yrs 59.1 yrs
% Female Patients 61.9% 66.6%
FDA Approval Date N/A Apr 9, 2019
Manufacturer Novartis Pharmaceuticals Corporation Novo Nordisk
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Discontinued